JPM Deals Recap: Boston Scientific Acquisition, A Mega Round For Parabilis, Enodia Emerges & More
Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup financings announced during the annual J.P. Morgan Healthcare Conference this year.